Ticker Scorecard - FHTX Basics Company: Foghorn Therapeutics Inc. IPO Date: October 23, 2020 Sector: Healthcare Industry: Biotech Market Cap: $279.08M Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 4.12% Avg Daily Range (30 D): $0.24 | 4.33% Avg Daily Range (90 D): $0.29 | 4.01% Institutional Daily Volume Avg Daily Volume: .11M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 86 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 79 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.51M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.7M Avg Closing Trade (30 D): $1.33M Avg Closing Trade (90 D): $2.65M Avg Closing Volume: 211.87K     News Oct 1, 2024 @ 11:00 AM Foghorn Therapeutics to Participate in the BMO Onc... Source: N/A Sep 24, 2024 @ 1:15 PM Optimism Grows in the Fight Against Cancer as Brea... Source: Prnewswire Sep 3, 2024 @ 8:48 PM Wall Street Analysts Think Foghorn Therapeutics Co... Source: Zacks Sep 3, 2024 @ 11:00 AM Foghorn Therapeutics Strengthens Leadership Team w... Source: N/A Aug 8, 2024 @ 11:00 AM Foghorn Therapeutics Provides Second Quarter 2024 ... Source: Foghorn Therapeutics Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.31 $-.45 $-.59 Diluted EPS $-.31 $-.45 $-.59 Revenue $ 7.81M $ 6.89M $ 5.05M Gross Profit $ $ $ Net Income / Loss $ -19.12M $ -22.98M $ -25.02M Operating Income / Loss $ -23.85M $ -26.63M $ -28.19M Cost of Revenue $ $ $ Net Cash Flow $ -81.27M $ 59.69M $ -1.08M PE Ratio